Urgent.News

What's breaking now, across thousands of outlets.

Business

Chemical industry: Evonik considers multi-billion dollar acquisition in the USA - Apparently no "poison pill" against BASF offer

The chemical group is not only a takeover target, but is itself on a shopping tour. According to information from the Handelsblatt, the group has been examining a possible large deal for months.

Translated from German Read in German

Chemical industry: Evonik considers multi-billion dollar acquisition in the USA - Apparently no "poison pill" against BASF offer

We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.

Read the original at handelsblatt.com →

More in Business

Daily Debrief: What Happened Today (Oct 22)

Stories you might have missed

  • Frasers Centerpoint Trust's distribution per unit increased by 2.6% to S$0.06214
  • Indonesia's sovereign wealth fund Danantara ready to deploy more capital into Indonesian stocks
  • Barclays plans to cut 5,000 jobs as part of AI-driven cost-cutting strategy

More from Thursday 22 October →